Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates

被引:13
作者
Mankowski, DC [1 ]
Lawton, MP [1 ]
Ekins, S [1 ]
机构
[1] Pfizer Inc, Div Cent Res, Groton, CT 06340 USA
关键词
D O I
10.1080/00498250050119817
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Transgenic mice were evaluated with six human cytochrome P450 (CYP) selective probe substrates, as little is known about their metabolism in the mouse. Mouse strains characterized include C57BL/SJL, FVB/N, mdr 1a/1b (-/-), ob/ob and ACCA. 2. Human CYP probe substrates used for characterization of mouse CYP activities included bufuralol, testosterone, dextromethorphan, phenacetin, diclofenac and S-mephenytoin. Activities were compared with those obtained in human liver microsomes and in human recombinant enzyme preparations. All transgenic mouse strains showed similar apparent K-m with bufuralol, testosterone and dextromethorphan which compared favourably with those observed in human liver microsomes. 3. K-m for phenacetin O-deethylase and S-mephenytoin 4'-hydroxylation were more variable across strains and in some cases demonstrated biphasic kinetics. Phenacetin O-deethylase activity was low in all mouse strains except FVB/N and mdr 1a/1b (-/-). Diclofenac 4-hydroxylation did not occur to any significant extent in the five strains of mouse evaluated here. 4. The findings suggest the validity of using five of the probes for transgenic mouse hepatic CYP characterization and gross comparison with data generated with human CYP.
引用
收藏
页码:745 / 754
页数:10
相关论文
共 40 条
[1]   ASSESSMENT OF THE MOUSE AS AN EXPERIMENTAL-MODEL FOR STUDYING POLYMORPHIC OXIDATION OF THE SPARTEINE DEBRISOQUINE TYPE [J].
ADAMS, M ;
LENNARD, MS ;
OTTON, SV ;
TUCKER, GT ;
WOODS, HF .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (04) :947-949
[2]  
Chemin I, 1996, HEPATOLOGY, V24, P649, DOI 10.1002/hep.510240330
[3]   Consequences of overexpression of growth hormone in transgenic mice on liver cytochrome P450 enzymes [J].
Cheriathundam, E ;
Doi, SQ ;
Knapp, JR ;
Jasser, MZ ;
Kopchick, JJ ;
Alvares, AP .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (09) :1481-1487
[4]  
CHRISTOPHERSON PA, 1995, ISSX P, V8, P358
[5]   Activity and inducibility of drug-metabolizing enzymes immortalized hepatocyte-like cells (mhPKT) derived from a L-PK/Tag1 transgenic mouse [J].
CourjaultGautier, F ;
Antoine, B ;
Bens, M ;
Vallet, V ;
Cluzeaud, F ;
Pringault, E ;
Kahn, A ;
Toutain, H ;
Vandewalle, A .
EXPERIMENTAL CELL RESEARCH, 1997, 234 (02) :362-372
[6]  
Ekins S, 1999, HANDBOOK OF DRUG METABOLISM, P363
[7]   Past, present, and future applications of precision-cut liver slices for in vitro xenobiotic metabolism [J].
Ekins, S .
DRUG METABOLISM REVIEWS, 1996, 28 (04) :591-623
[8]   Examination of purported probes of human CYP2B6 [J].
Ekins, S ;
VandenBranden, M ;
Ring, BJ ;
Wrighton, SA .
PHARMACOGENETICS, 1997, 7 (03) :165-179
[9]  
EKINS S, 1996, THESIS U ABERDEEN
[10]  
GUENGERICH FP, 1977, J BIOL CHEM, V252, P3970